Search

Search Results

• Isotretinoin musculoskeletal side effects: a systematic review

  Rahaf R. Almutairi, Atheer G. Almutairi, Afnan F. Alhallafi, Norah A. Almudawi, Mohammed Abdulaziz AlSulaiman, Asem M. Shadid, Ruaa Alharithy

  12-04-2024

  https://doi.org/10.4081/dr.2024.9845

  6279

  PDF: 1232

  SUPPLEMENTARY: 470

  HTML: 505
• 

  Lupus pernio (Besnier-Tenneson syndrome): A rare form of sarcoidosis

  Amal Hubail, Roza Belkharoeva, Natalya Tepluk, Tatyana Belerosova

  01-10-2018

  https://doi.org/10.4081/dr.2018.7696

  2475

  PDF: 866

  HTML: 392
• 

  Delayed immune mediated adverse effects to hyaluronic acid fillers: report of five cases and review of the literature

  Ora Bitterman-Deutsch, Leonid Kogan, Faris Nasser

  30-03-2015

  https://doi.org/10.4081/dr.2015.5851

  4481

  PDF: 1725

  HTML: 1985
• 

  Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma

  Yukari Matsumoto, Takeshi Fukumoto, Wakako Takahashi, Chikako Nishigori

  29-12-2022

  https://doi.org/10.4081/dr.2023.9617

  887

  PDF: 466

  HTML: 51

• Gemcitabine, a rare cause of chemotherapy-related reticulate hyperpigmentation

  Francesco Savoia, Matelda Medri, Alessandro Passardi, Davide Melandri, Ignazio Stanganelli

  02-02-2024

  https://doi.org/10.4081/dr.2024.9872

  773

  PDF: 515

  HTML: 47

• Acute generalized exanthematous pustulosis triggered by dupilumab

  Caterina Mariarosaria Giorgio, Gaetano Licata, Giuseppe Argenziano, Vittorio Tancredi, Anna Balato, Eugenia Veronica Di Brizzi

  23-07-2025

  https://doi.org/10.4081/dr.2025.10219

  551

  PDF: 359

  HTML: 28
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  1374

  PDF: 642

  HTML: 29

• A microRNA focus on acne

  Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

  02-02-2024

  https://doi.org/10.4081/dr.2024.9902

  1165

  PDF: 751

  HTML: 75

• Efficacy and safety of topical sofpironium bromide in treating primary axillary hyperhidrosis: systematic review and meta-analysis of randomized controlled trials

  Yuichiro Oshima, Takashi Hashimoto, Hiroshi Miyama, Tomoko Fujimoto

  16-06-2026

  https://doi.org/10.4081/dr.2026.10853

  1064

  PDF: 405
• 

  Transient cutaneous hypomelanosis after cryoanesthesia

  Roberto Pippi, Martina Caputo, Alessandra Pietrantoni

  06-07-2022

  https://doi.org/10.4081/dr.2022.9528

  1023

  PDF: 462

  HTML: 34

• Does the response to bimekizumab vary according to previous therapy with methotrexate versus cyclosporine?

  Ilaria Salvi, Alexandra M. G. Brunasso, Franco Castelli, Andrea Michelerio, Paolo Pella, Marco Rubatto, Paolo Dapavo, Emanuele Cozzani, Martina Burlando

  20-03-2026

  https://doi.org/10.4081/dr.2026.10236

  360

  PDF: 308

• Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

  Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi

  16-10-2025

  https://doi.org/10.4081/dr.2025.10588

  462

  PDF: 234

  HTML: 4
• 

  A lobulated mass on the upper back with prominent vasculature: A giant basal cell carcinoma

  Elysha M. Kolitz, Brian L. Scott , Travis Vandergriff, Melissa Mauskar

  07-04-2021

  https://doi.org/10.4081/dr.2021.9046

  3632

  PDF: 627

  HTML: 1175
• 

  Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

  Federica Mola, Alberico Motolese

  e40

  03-10-2011

  https://doi.org/10.4081/dr.2011.e40

  1318

  PDF: 621

  HTML: 1093

• 24 | IXEKIZUMAB WITH OR WITHOUT TIRZEPATIDE IN ADULTS WITH PSORIASIS AND OVERWEIGHT OR OBESITY: THE TOGETHER-PSO PHASE 3B RANDOMIZED CLINICAL TRIAL E. Filippi¹, M. Lebwohl², A. Blauvelt³, C. Kartman⁴, C. Leatherwood⁴, K. Gordon⁵, N. Sattar⁶, L. Puig⁷, J. Merola⁸, K. Siu⁴, R. Wang⁴, L. Sun⁴, A. Leung⁹, N. Somani⁴, M. Rueda⁴, A. Cardoso⁴, M. Genovese⁴, A. Armstrong¹⁰, B. Strober¹¹ | ¹Eli Lilly Italy S.p.A, Sesto Fiorentino, Italy; ²Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; ³Blauvelt Consulting, LLC, Annapolis, MD, USA; ⁴Eli Lilly and Company, Indianapolis, IN, USA; ⁵Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA; ⁶School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; ⁷Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain; ⁸Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; ⁹Syneos Health, Morrisville, NC, USA; ¹⁰Division of Dermatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA; ¹¹Department of Dermatology, Yale University School of Medicine, New Haven, CT, Central Connecticut Dermatology Research, Cromwell, CT, USA

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11086

  119

  PDF: 42

• Disseminated superficial actinic porokeratosis in an elderly patient undergoing androgen deprivation therapy for advanced prostate cancer: exploring the potential association

  Paulus Anthony Halim, Shannaz Nadia Yusharyahya, Lili Legiawati, Rinadewi Astriningrum, Sondang P. Sirait

  24-01-2024

  https://doi.org/10.4081/dr.2024.9850

  1437

  PDF: 680

  HTML: 36
• 

  Secondary prevention of hidradenitis suppurativa

  Hjalmar Kurzen, Marina Kurzen

  25-10-2019

  https://doi.org/10.4081/dr.2019.8243

  3132

  PDF: 1255

  HTML: 45

• Pregnancy and lactation during anifrolumab treatment in systemic lupus erythematosus

  Maria Bernadette Cilona, Giovanni Paolino, Luca Moroni, Giuseppe Alvise Ramirez, Federica Pasi, Eleonora Sabetta, Antonella Poloniato, Federica Barzaghi, Maria Teresa Castiglioni, Valentina Canti

  14-07-2026

  https://doi.org/10.4081/dr.2026.10921

  357

  PDF: 264
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  https://doi.org/10.4081/dr.2022.9566

  1989

  PDF: 758

  HTML: 54

• Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion

  Gaia Fasano, Giancarlo Valenti, Domenico D'Amico, Mario Valenti

  24-08-2023

  https://doi.org/10.4081/dr.2023.9803

  984

  PDF: 526

  HTML: 193
• 

  Hematohidrosis induced by separation anxiety disorder during COVID-19 quarantine: a case report and brief literature review

  Hao Trong Nguyen, Phuong Thi Doan Vo, Trinh Thi Diem Nguyen, Quynh Truc Nguyen, Dao Le Truong

  23-12-2022

  https://doi.org/10.4081/dr.2023.9615

  1288

  PDF: 548

  HTML: 354
• 

  The efficacy and safety of fractional erbium yag laser combined with topical amniotic membrane stem cell (AMSC) metabolite product for facial rejuvenation: A controlled, split-face study

  Ni Putu Susari Widianingsih, Trisniartami Setyaningrum, Cita Rosita S. Prakoeswa

  29-03-2019

  https://doi.org/10.4081/dr.2019.8036

  1618

  PDF: 709
• 

  Granuloma faciale in a patient with remitting seronegative symmetric synovitis with pitting edema

  Abdurhman Saud Al Arfaj, Najma Khalil, Malak Alzahrani, Sufia Husain

  22-05-2023

  https://doi.org/10.4081/dr.2023.9725

  811

  PDF: 409

  HTML: 25
• 

  Chromoblastomycosis evolving to sarcomatoid squamous cell carcinoma: A case report

  Walter Belda Jr., Paulo Ricardo Criado, Paula Casteleti, Luiz Felipe Domingues Passero

  05-08-2021

  https://doi.org/10.4081/dr.2021.9009

  2499

  PDF: 577

  HTML: 90

• Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after checkpoint inhibitor treatment: a case report

  Carlotta Bertolina, Marinella Bertolotti, Claudia Leporati, Antonina Maria De Angelis, Sara Delfanti, Luigi Cerbone, Marco Ghiglione, Federica Grosso

  17-06-2025

  https://doi.org/10.4081/dr.2025.10324

  606

  PDF: 352

  HTML: 33